URGN UroGen Pharma Ltd.

NASDAQ

$41.35

UroGen Pharma Ltd. (URGN) Earnings News

Earnings press releases, previews and reviews for UroGen Pharma Ltd. (URGN), newest first.

Wednesday August 5, 2026 8:00 AM ET

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Wednesday July 29, 2026 8:00 AM ET

UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026

Wednesday May 6, 2026 8:00 AM ET

UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights

Wednesday April 29, 2026 8:00 AM ET

UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026